Dapagliflozin Pharmacokinetics Is Similar in Adults With Type 1 and Type 2 Diabetes Mellitus

Dapagliflozin improves glycemic control in patients with type 2 diabetes mellitus (T2DM) and is approved in Japanese patients with type 1 diabetes mellitus (T1DM) with inadequate glycemic control. The objectives of this work were to characterize the dapagliflozin pharmacokinetics (PK) in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Melin, Johanna, Tang, Weifeng, Rekić, Dinko, Hamrén, Bengt, Penland, Robert C., Boulton, David W., Parkinson, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Pharmacokinetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545191/
https://www.ncbi.nlm.nih.gov/pubmed/35403243
http://dx.doi.org/10.1002/jcph.2062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545191/
https://www.ncbi.nlm.nih.gov/pubmed/35403243
http://dx.doi.org/10.1002/jcph.2062

Ejemplares similares